## Abstract ## Background This study aimed to investigate the effect of risperidone on the behavioural and psychological symptoms (BPS), cognitive function and activities of daily living (ADL) of Alzheimer's disease (AD). The optimal dose of risperidone in Korean patients with AD was determined wi
Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease
✍ Scribed by M. J. Gonzalez-Moneo; M. Simó; M. Pie; D. Rivero
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 42 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2011
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Setting Treating elderly patients with Alzheimer's disease (AD) and behavioral and psychological symptoms of dementia (BPSD) is challenging due to the increased risk of iatrogenic movement disorders with old neuroleptics and the seemingly increasing risk of cardiovascular events wit
## Abstract ## Objectives The economic and psychosocial impacts of Alzheimer's disease (AD) on caregivers are so well documented that they have stimulated socioeconomic regulations that are international in scope. In Italy caregivers have the right to receive economic and psychosocial aid. However
Assess long-term cost-effectiveness of rivastigmine patch in Alzheimer's disease (AD) management in the UK, using cognitive and functional models based on clinical trial efficacy data. Methods: Incremental costs and Quality Adjusted Life Years (QALYs) associated with rivastigmine patch and capsule t
A common polymorphism in the α1-antichymotrypsin (ACT) gene has been found to modify the APOE\*4-associated risk of Alzheimer's disease due to an apparent interaction between the two loci. This study was undertaken to determine the gender-and age-related distributions of these two polymorphisms in t